Skip to main content
Fig. 2 | BMC Musculoskeletal Disorders

Fig. 2

From: Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model

Fig. 2

Ultrasonographic parameters: a representative transverse images obtained from the MSC-injected and the contralateral superficial digital flexor tendons 3, 12 and 24 weeks after MSC injection; the respective tendon is indicated by the white line in the first upper image; note the hypoechoic (dark) lesions within the tendons, which are decreasing over time. Diagrams displaying mean (± 2 SD) values of b ultrasonography score and c percentage of the lesion within the cross-sectional area (CSA) of the tendon over the whole follow-up period; stars indicate significant differences between MSC-injected and contralateral tendons (p < 0.05); wk.: week post MSC injection

Back to article page